Reviews & Commentaries

This section provides a list of selected DCIS research reviews published since 2002. If you would like to add other relevant reviews to this list, please contact us.

2011

Virnig BA, Tuttle TM. Random physician effect and comparative effectiveness of treatment for ductal carcinoma in situ. J Natl Cancer Inst 2011 Jan 19;103(2):81-2. [Look up in PubMed]

2010

Allred DC. Ductal carcinoma in situ: terminology, classification, and natural history. J Natl Cancer Inst Monogr 2010;2010(41):134-8. Review. [View Abstract]

Bijker N, van Tienhoven G. Local and systemic outcomes in DCIS based on tumor and patient characteristics: the radiation oncologist's perspective. J Natl Cancer Inst Monogr 2010;2010(41):178-80. Review. [View Abstract]

D'Orsi CJ. Imaging for the diagnosis and management of ductal carcinoma in situ. J Natl Cancer Inst Monogr 2010;2010(41):214-7. Review. [View Abstract]

Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Correa C, McGale P, Taylor C, Wang Y, Clarke M, Davies C, Peto R, Bijker N, Solin L, Darby S. Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr 2010;2010(41):162-77. Review. [View Abstract]

Elmore JG, Ganschow PS, Geller BM. Communication between patients and providers and informed decision making. J Natl Cancer Inst Monogr 2010;2010(41):204-9. Review. [View Abstract]

Eng-Wong J, Costantino JP, Swain SM. The impact of systemic therapy following ductal carcinoma in situ. J Natl Cancer Inst Monogr 2010;2010(41):200-3. Review. [View Abstract]

Flanagan M, Love S, Hwang ES. Status of Intraductal Therapy for Ductal Carcinoma in Situ. Curr Breast Cancer Rep 2010 Jun;2(2):75-82. [View Abstract]

Ganz PA. Quality-of-life issues in patients with ductal carcinoma in situ. J Natl Cancer Inst Monogr 2010;2010(41):218-22. Review. [View Abstract]

Hwang ES. The impact of surgery on ductal carcinoma in situ outcomes: the use of mastectomy. J Natl Cancer Inst Monogr 2010;2010(41):197-9. Review. [View Abstract]

Kane RL, Virnig BA, Shamliyan T, Wang SY, Tuttle TM, Wilt TJ. The impact of surgery, radiation, and systemic treatment on outcomes in patients with ductal carcinoma in situ. J Natl Cancer Inst Monogr 2010;2010(41):130-3. Review. [View Abstract]

Kerlikowske K. Epidemiology of ductal carcinoma in situ. J Natl Cancer Inst Monogr 2010;2010(41):139-41. Review. [View Abstract]

Lagios MD, Silverstein MJ. Ductal carcinoma in situ: dilemma or denouement. J Clin Oncol 2010 May 10;28(14):e218-9; author reply e220. [Look up in PubMed]

Lehman CD. Magnetic resonance imaging in the evaluation of ductal carcinoma in situ. J Natl Cancer Inst Monogr 2010;2010(41):150-1. Review. [View Abstract]

Nelson NJ. DCIS prognostic markers: a few new candidates emerge. J Natl Cancer Inst 2010 May 5;102(9):588-90. [Look up in PubMed]

Newman LA. Local control of ductal carcinoma in situ based on tumor and patient characteristics: the surgeon's perspective. J Natl Cancer Inst Monogr 2010;2010(41):152-7. Review. [View Abstract]

Patani N, Khaled Y, Al Reefy S, Mokbel K. Ductal carcinoma in-situ: an update for clinical practice. Surg Oncol 2011 Mar;20(1):e23-31. [View Abstract]

Pisano ED. Mode of detection and secular time for ductal carcinoma in situ. J Natl Cancer Inst Monogr 2010;2010(41):142-4. Review. [View Abstract]

Polyak K. Molecular markers for the diagnosis and management of ductal carcinoma in situ. J Natl Cancer Inst Monogr 2010;2010(41):210-3. Review. [View Abstract]

Schnitt SJ. Local outcomes in ductal carcinoma in situ based on patient and tumor characteristics. J Natl Cancer Inst Monogr 2010;2010(41):158-61. Review. [View Abstract]

Shapiro-Wright HM, Julian TB. Sentinel lymph node biopsy and management of the axilla in ductal carcinoma in situ. J Natl Cancer Inst Monogr 2010;2010(41):145-9. Review. [View Abstract]

Solin LJ. The impact of adding radiation treatment after breast conservation surgery for ductal carcinoma in situ of the breast. J Natl Cancer Inst Monogr 2010;2010(41):187-92. Review. [View Abstract]

Virnig BA, Wang SY, Shamilyan T, Kane RL, Tuttle TM. Ductal carcinoma in situ: risk factors and impact of screening. J Natl Cancer Inst Monogr 2010;2010(41):113-6. Review. [View Abstract]

2009

Benson JR. Will ductal carcinoma in situ defeat breast cancer screening? BMJ 2009 Mar 9;338:b957. doi: 10.1136/bmj.b957. [Look up in PubMed]

Flanders J. Breast screening. Reality of ductal carcinoma in situ. BMJ 2009 Mar 9;338:b958. doi: 10.1136/bmj.b958. [Look up in PubMed]

Goodwin A, Parker S, Ghersi D, Wilcken N. Post-operative radiotherapy for ductal carcinoma in situ of the breast. Cochrane Database Syst Rev 2009 Jul 8;(3):CD000563. Review. [View Abstract]

Kuerer HM, Albarracin CT, Yang WT, Cardiff RD, Brewster AM, Symmans WF, Hylton NM, Middleton LP, Krishnamurthy S, Perkins GH, Babiera G, Edgerton ME, Czerniecki BJ, Arun BK, Hortobagyi GN. Ductal carcinoma in situ: state of the science and roadmap to advance the field. J Clin Oncol 2009 Jan 10;27(2):279-88. Review. [View Abstract]

Lagios M. Therapeutic decisions for ductal carcinoma in situ: a Gordian knot. Breast J 2009 Mar-Apr;15(2):117-9. [Look up in PubMed]

Schnitt SJ. The transition from ductal carcinoma in situ to invasive breast cancer: the other side of the coin. Breast Cancer Res 2009;11(1):101. [View Abstract]

Schouten van der Velden AP, Schlooz-Vries MS, Boetes C, Wobbes T. Magnetic resonance imaging of ductal carcinoma in situ: what is its clinical application? A review. Am J Surg 2009 Aug;198(2):262-9. Review. [View Abstract]

2008

Lagios MD, Silverstein MJ. Ductal carcinoma in situ: through a glass, darkly. Ann Surg Oncol 2008 Jan;15(1):16-7. [Look up in PubMed]

Morrow M. Magnetic resonance imaging in the breast cancer patient: curb your enthusiasm. J Clin Oncol 2008 Jan 20;26(3):352-3. [Look up in PubMed]

Ransohoff DF. The process to discover and develop biomarkers for cancer: a work in progress. J Natl Cancer Inst 2008 Oct 15;100(20):1419-20. [Look up in PubMed]

Sakorafas GH, Farley DR, Peros G. Recent advances and current controversies in the management of DCIS of the breast. Cancer Treat Rev 2008 Oct;34(6):483-97. [View Abstract]

Smith BD, Smith GL, Buchholz TA. Controversies over the role of radiation therapy for ductal carcinoma in situ. Expert Rev Anticancer Ther 2008 Mar;8(3):433-41. [View Abstract]

Welch HG, Woloshin S, Schwartz LM. The sea of uncertainty surrounding ductal carcinoma in situ--the price of screening mammography. J Natl Cancer Inst 2008 Feb 20;100(4):228-9. [Look up in PubMed]

Wiechmann L, Kuerer HM. The molecular journey from ductal carcinoma in situ to invasive breast cancer. Cancer 2008 May 15;112(10):2130-42. [View Abstract]

2007

Boughey JC, Gonzalez RJ, Bonner E, Kuerer HM. Current treatment and clinical trial developments for ductal carcinoma in situ of the breast. Oncologist 2007 Nov;12(11):1276-87. [View Abstract]

Czerniecki BJ, Roses RE, Koski GK. Development of vaccines for high-risk ductal carcinoma in situ of the breast. Cancer Res 2007 Jul 15;67(14):6531-4. [View Abstract]

Irvine T, Fentiman IS. Biology and treatment of ductal carcinoma in situ. Expert Rev Anticancer Ther 2007 Feb;7(2):135-45. [View Abstract]

Morrow M, O'Sullivan MJ. The dilemma of DCIS. Breast 2007 Dec;16 Suppl 2:S59-62. [View Abstract]

O'Sullivan MJ, Morrow M. Ductal carcinoma in situ--current management. Surg Clin North Am 2007 Apr;87(2):333-51, viii. [View Abstract]

Patani N, Cutuli B, Mokbel K. Current management of DCIS: a review. Breast Cancer Res Treat 2008 Sep;111(1):1-10. [View Abstract]

Tang P, Hajdu SI, Lyman GH. Ductal carcinoma in situ: a review of recent advances. Curr Opin Obstet Gynecol 2007 Feb;19(1):63-7. [View Abstract]

Valenzuela M, Julian TB. Ductal carcinoma in situ: biology, diagnosis, and new therapies. Clin Breast Cancer 2007 Aug;7(9):676-81. [View Abstract]

2006

Erbas B, Provenzano E, Armes J, Gertig D. The natural history of ductal carcinoma in situ of the breast: a review. Breast Cancer Res Treat 2006 May;97(2):135-44. Epub 2005 Dec 1. [View Abstract]

Jones JL. Overdiagnosis and overtreatment of breast cancer: progression of ductal carcinoma in situ: the pathological perspective. Breast Cancer Res 2006;8(2):204. Epub 2006 Apr 21. [View Abstract]

Mokbel K, Cutuli B. Heterogeneity of ductal carcinoma in situ and its effects on management. Lancet Oncol 2006 Sep;7(9):756-65. [View Abstract]

Tsikitis VL, Chung MA. Biology of ductal carcinoma in situ classification based on biologic potential. Am J Clin Oncol 2006 Jun;29(3):305-10. [View Abstract]

2005

Nofech-Mozes S, Spayne J, Rakovitch E, Hanna W. Prognostic and predictive molecular markers in DCIS: a review. Adv Anat Pathol 2005 Sep;12(5):256-64. [View Abstract]

van de Vijver MJ. Biological variables and prognosis of DCIS. Breast 2005 Dec;14(6):509-19. Epub 2005 Oct 24. [View Abstract]

2004

Khan A, Newman LA. Diagnosis and management of ductal carcinoma in situ. Curr Treat Options Oncol2004 Apr;5(2):131-44. [View Abstract]

Leonard GD, Swain SM. Ductal carcinoma in situ, complexities and challenges. J Natl Cancer Inst 2004 Jun 16;96(12):906-20. [View Abstract]

2003

Evans A. The diagnosis and management of pre-invasive breast disease: radiological diagnosis. Breast Cancer Res 2003;5(5):250-3. Epub 2003 Jul 29. [View Abstract]

Jeffrey SS, Pollack JR. The diagnosis and management of pre-invasive breast disease: promise of new technologies in understanding pre-invasive breast lesions. Breast Cancer Res 2003;5(6):320-8. Epub 2003 Oct 9. [View Abstract]

Nakhlis F, Morrow M. Ductal carcinoma in situ. Surg Clin North Am 2003 Aug;83(4):821-39. [View Abstract]

Nerurkar A, Osin P. The diagnosis and management of pre-invasive breast disease: the role of new diagnostic techniques. Breast Cancer Res 2003;5(6):305-8. Epub 2003 Oct 9. [View Abstract]

Pinder SE, Ellis IO. The diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH)--current definitions and classification. Breast Cancer Res 2003;5(5):254-7. Epub 2003 Jul 29. [View Abstract]

Purushotham AD. The diagnosis and management of pre-invasive breast disease: problems associated with management of pre-invasive lesions. Breast Cancer Res 2003;5(6):309-12. Epub 2003 Oct 9. [View Abstract]

Reis-Filho JS, Lakhani SR. The diagnosis and management of pre-invasive breast disease: genetic alterations in pre-invasive lesions. Breast Cancer Res 2003;5(6):313-9. Epub 2003 Oct 9. [View Abstract]

Silverstein MJ. An argument against routine use of radiotherapy for ductal carcinoma in situ. Oncology (Williston Park). 2003 Nov;17(11):1511-33; discussion 1533-4, 1539, 1542 passim. [View Abstract]

2002

Jaffer S, Bleiweiss IJ. Histologic classification of ductal carcinoma in situ. Microsc Res Tech 2002 Oct 15;59(2):92-101. [View Abstract]

Morrow M, Strom EA, Bassett LW, Dershaw DD, Fowble B, Giuliano A, Harris JR, O'Malley F, Schnitt SJ, Singletary SE, Winchester DP; American College of Radiology; American College of Surgeons; Society of Surgical Oncology; College of American Pathology. Standard for breast conservation therapy in the management of invasive breast carcinoma. CA Cancer J Clin 2002 Sep-Oct;52(5):277-300. [View Abstract]

Schwartz GF, Terribile D. The treatment of ductal carcinoma in situ of the breast. Obstet Gynecol Clin North Am 2002 Mar;29(1):189-200, viii-ix. [View Abstract]

Vicini FA, Recht A. Age at diagnosis and outcome for women with ductal carcinoma-in-situ of the breast: a critical review of the literature. J Clin Oncol 2002 Jun 1;20(11):2736-44. [View Abstract]